Mitiglinide Calcium Dihydrate CAS 207844-01-7 Assay >99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Mitiglinide Calcium Dihydrate (CAS: 207844-01-7) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Mitiglinide Calcium Dihydrate, Please contact: alvin@ruifuchem.com
| Chemical Name | Mitiglinide Calcium Dihydrate |
| Synonyms | KAD-1229 Calcium Hydrate; (aS,3aR,7aS)-Octahydro-gamma-oxo-alpha-(Phenylmethyl)-2H-Isoindole-2-Butanoic Acid Calcium Salt Dihydrate; (S)-2-Benzyl-4-oxo-4-(cis-Perhydroisoindol-2-yl)butyric Acid Calcium Salt Dihydrate |
| Stock Status | In Stock, Commercial Production |
| CAS Number | 207844-01-7 |
| Molecular Formula | C38H52CaN2O8 |
| Molecular Weight | 704.91 g/mol |
| Melting Point | 179.0~185.0℃ |
| COA & MSDS | Available |
| Sample | Available |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Items | Specifications | Results |
| Appearance | White or Almost White Powder | White Powder |
| Identification A | It should show forward reaction | Complies |
| Identification B | In the chromatogram of assay, the retention time of the main peak is the same as reference |
Complies |
| Identification C | The infrared absorption is the same as reference | Complies |
| Related Substances | ||
| Any Other Impurity | <0.20% | 0.05% |
| Total Impurities | <0.50% | 0.15% |
| Laevo Isomer | <0.50% | 0.11% |
| Alcohol | <0.50% | <0.50% |
| Methanol | <0.30% | <0.30% |
| Loss on Drying | 4.5%~6.0% | 5.3% |
| Chlorides | <0.07% | <0.07% |
| Heavy Metals | <20ppm | <20ppm |
| Ca (on Dried Basis) | 5.5%~6.5% | 6.0% |
| Assay | >99.0% (on Dried Basis) | 99.77% |
| Conclusion | The product has been tested and complies with the given specifications | |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protection from direct sunlight and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Mitiglinide Calcium Dihydrate (CAS: 207844-01-7), clinically used for the treatment of type II diabetes. It was developed by Kissei Pharmaceutical Company of Japan and was first listed in Japan in May 2004. Antidiabetic. Mitiglinide Calcium is the third meglitamide after Repaglinide and Nateglinide, it is an ATP-dependent potassium channel blocker, which is a derivative of phenylalanine. Its mechanism of action is similar to sulfonylurea, but it has faster onset and short half-life, which is beneficial to reducing postprandial blood glucose in diabetic patients, it can also avoid hypoglycemia caused by continuous hypoglycemic, with the name of "In vitro pancreas.
Improvement of postprandial hyperglycemia in patients with type 2 diabetes mellitus, exercise therapy can not effectively control blood sugar patients or diet, exercise therapy based on the addition of alpha-glucosidase inhibitors still can not effectively control blood sugar patients).
